Evidence map›Paper›PMID 37375411›Full record

ReviewMolecules (Basel, Switzerland)2023

Pentagalloyl Glucose: A Review of Anticancer Properties, Molecular Targets, Mechanisms of Action, Pharmacokinetics, and Safety Profile.

Chengli Wen, Nathupakorn Dechsupa, Zehui Yu, Xu Zhang, Sicheng Liang, Xianying Lei, Tao Xu, Xiaolan Gao, Qinxue Hu, Phattarawadee Innuan and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Chemical Characteristics and Antimicrobial Activity ofMolecules (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Article
  5. Anti-Amyloid Aggregation Effects of Gobaishi (Molecules (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Antimicrobial agents and chemotherapy · 2025
    Article
  10. KRASCell reports. Medicine · 2025
    Article
  11. Frontiers in pharmacology · 2025
    Article
  12. Article
  13. Pentagalloyl Glucose fromPharmaceuticals (Basel, Switzerland) · 2024
    Article
  14. Molecules (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Article
  17. Ethanolic Extract from Fruits ofPlants (Basel, Switzerland) · 2024
    Article
  18. Phytochemical Profiling and Biological Activities ofPlants (Basel, Switzerland) · 2023
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Chengli WenDepartment of Intensive Care Medicine, Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Nathupakorn DechsupaMolecular Imaging and Therapy Research Unit, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-0412-9659
Zehui YuLaboratory Animal Center, Southwest Medical University, Luzhou 646000, China.ORCID 0000-0003-0435-1548
Xu ZhangLuzhou Key Laboratory of Human Microecology and Precision Diagnosis and Treatment, Luzhou 646000, China.ORCID 0000-0002-3323-8491
Sicheng LiangLuzhou Key Laboratory of Human Microecology and Precision Diagnosis and Treatment, Luzhou 646000, China.
Xianying LeiDepartment of Intensive Care Medicine, Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Tao XuDepartment of Intensive Care Medicine, Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Xiaolan GaoDepartment of Intensive Care Medicine, Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Qinxue HuDepartment of Intensive Care Medicine, Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Phattarawadee InnuanMolecular Imaging and Therapy Research Unit, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
Jiraporn KantapanMolecular Imaging and Therapy Research Unit, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-0480-3575
Muhan LüLuzhou Key Laboratory of Human Microecology and Precision Diagnosis and Treatment, Luzhou 646000, China.
Affiliated Hospital of Southwest Medical University · CNChiang Mai University · THSouthwest Medical University · CN

Funding

Sichuan Science and Technology Program 2022YFS0626Southwest Medical University 2022YFS0626
6 · The paper itself

Abstract

Pentagalloyl glucose (PGG) is a natural hydrolyzable gallotannin abundant in various plants and herbs. It has a broad range of biological activities, specifically anticancer activities, and numerous molecular targets. Despite multiple studies available on the pharmacological action of PGG, the molecular mechanisms underlying the anticancer effects of PGG are unclear. Here, we have critically reviewed the natural sources of PGG, its anticancer properties, and underlying mechanisms of action. We found that multiple natural sources of PGG are available, and the existing production technology is sufficient to produce large quantities of the required product. Three plants (or their parts) with maximum PGG content were Rhus chinensis Mill, Bouea macrophylla seed, and Mangifera indica kernel. PGG acts on multiple molecular targets and signaling pathways associated with the hallmarks of cancer to inhibit growth, angiogenesis, and metastasis of several cancers. Moreover, PGG can enhance the efficacy of chemotherapy and radiotherapy by modulating various cancer-associated pathways. Therefore, PGG can be used for treating different human cancers; nevertheless, the data on the pharmacokinetics and safety profile of PGG are limited, and further studies are essential to define the clinical use of PGG in cancer therapies.

Indexed as

GlucoseHydrolyzable TanninsHumansGlucoseHydrolyzable Tanninspentagalloylglucoseanticancergallotanninmechanismsmolecular targetspentagalloyl glucosepharmacokineticssafety profile

Identifiers

PMID37375411
PMCPMC10300743
OpenAlexW4381435958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.